CS logo
small CS logo
Texas Diabetes Institute

San Antonio, Texas, United States
Diabetes center in San Antonio, Texas
701 S Zarzamora St, San Antonio, TX 78207

About Texas Diabetes Institute


"University Health Texas Diabetes Institute offers high-quality healthcare services to adults including chronic disease management, preventive care and treatment for minor illnesses. Our Pharmacy offers free walk-in COVID-19 vaccinations including 1st dose and 2nd dose for people 12 and older, and 3rd dose and booster shots for those currently eligible, Monday – Friday 8 a.m. – 5 p.m."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
The University of Texas Health Science Center at San Antonio
15
Boehringer Ingelheim
1
Fractyl Laboratories, Inc.
1
GMP Endotherapeutics
1
Mannkind Corporation
1
Xeris Pharmaceuticals
1
Total Rows: 6

Clinical Trials at Texas Diabetes Institute


During the past decade, Texas Diabetes Institute conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11000033221133110022000000000011Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients
2001-12-01
Completed
62
Actos Now for Prevention of Diabetes (ACT NOW)
2004-01-01
2010-04-01
Completed
602
Evaluating the Effects of Foot Orthotics on Plantar Pressures in the Diabetic Population
2005-08-01
2011-08-01
Completed
65
An Open-label, Multi-center, International, Three-year, Safety and Tolerability 'Follow on' Trial
2004-05-01
2008-10-01
Completed
229
Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM
2009-10-01
2012-10-01
Completed
16
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
2009-10-01
2024-08-01
Recruiting
160
Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM
2009-01-01
2024-12-01
Active, not recruiting
521
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
2005-11-01
2024-08-01
Recruiting
80

Rows per page:

1–20 of 20

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Texas Diabetes Institute" #1 sponsor was "The University of Texas Health Science Center at San Antonio" with 15 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Fractyl Laboratories, Inc." with 1 trials sponsored, "GMP Endotherapeutics" with 1 trials sponsored and "Mannkind Corporation" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Diabetes Institute" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 7 trials as a collaborator, "American Diabetes Association" with 1 trials as a collaborator, "Amylin Pharmaceuticals, LLC." with 1 trials as a collaborator, "Doris Duke Charitable Foundation" with 1 trials as a collaborator and "Emissary International LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Texas Diabetes Institute


According to Clinical.Site data, the most researched conditions in "Texas Diabetes Institute" are "Type 2 Diabetes" (4 trials), "Diabetes" (3 trials), "Diabetes Mellitus, Type 2" (3 trials), "Hypoglycemia" (2 trials) and "Type 2 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "Texas Diabetes Institute" in a lesser frequency.

Clinical Trials Intervention Types at Texas Diabetes Institute


Most popular intervention types in "Texas Diabetes Institute" are "Drug" (17 trials), "Other" (3 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Atropine" (2 trials), "Exendin-(9-39)" (2 trials), "Pioglitazone" (2 trials) and "Beta-hydroxy-butyrate" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Texas Diabetes Institute


The vast majority of trials in "Texas Diabetes Institute" are 20 trials for "All" genders.

Clinical Trials Status at Texas Diabetes Institute


Currently, there are NaN active trials in "Texas Diabetes Institute". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Texas Diabetes Institute, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Texas Diabetes Institute, 4 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status